Physician profile
John S Mason
NPI 1174596472
$2,928.65
in general payments reported to CMS, 2019-2025
18 companies · $577 in 2025
The $577 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2020: $205 · 2021: $180 · 2022: $449 · 2023: $521 · 2024: $418 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $872.03 | 2022-2025 | Miebo, Xiidra, Infuse |
| Alcon Vision LLC | $799.69 | 2019-2025 | Tryptyr, Total30, Simbrinza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $346.68 | 2019-2021 | |
| Coopervision INC. | $177.06 | 2019-2022 | |
| New World Medical,INC. | $124.24 | 2023 | |
| Optos, INC. | $122.89 | 2019 | |
| Allergan, INC. | $117.25 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $69.38 | 2019-2025 | |
| Abbvie INC. | $53.31 | 2024-2025 | |
| Thea Pharma INC. | $46.19 | 2023 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $36.99 | 2021-2024 | |
| Harrow Eye, LLC | $30.99 | 2025 | Vevye |
| Carl Zeiss Meditec, INC. | $29.86 | 2019 | |
| Oyster Point Pharma, INC. | $28.10 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.32 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $19.87 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Aerie Pharmaceuticals, INC. | $14.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.